Qiming-Backed AI Drug Discovery Startup Insilico Medicine Files For Hong Kong IPO
Insilico Medicine was valued at about $895 million after raising $95 million last July from the likes of leading Chinese healthcare-focused firm Qiming Venture Partners and billionaire Eduardo Saverin’s B Capital, among others.
Tags : Insilico Medicine AI drug discovery Hong Kong startup Hong Kong IPO Eli Lilly AI Pfizer AI Biotech
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.